ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

Brain tumor foundations form collaboration.

July 15, 2005

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978